TRiCBIO
TechnologyNavigation menu
R&D ServicesModels & ProductsApplicationsTechnologyEvidence & ResourcesHow We WorkAbout TRiCBIOProject inquiry中文

From organoids to in vivo validation

PDOX in vivo validation

Extend selected patient-derived organoid (PDO) findings into xenograft studies to compare tumor growth, pharmacology and mechanism-related readouts across models.

Study applications

When in vivo extension adds value

01

An in vitro PDO study has produced a response worth testing in vivo

02

Assess in vivo growth or histology

03

Compare key efficacy or mechanism findings in vitro and in vivo

Study workflow

Move from PDO findings into a PDOX study

01

PDO identity and study selection

Confirm model source, morphology, key markers and in vitro evidence.

02

In vivo study design

Define animal, implantation route, observation period, groups and primary endpoints.

03

Growth and histologic validation

Track in vivo growth and confirm identity using H&E or project-relevant markers.

04

In vitro–in vivo comparison

Compare key efficacy, histologic or mechanism signals across both systems.

Deliverables

Receive in vivo growth, histology and efficacy results

  • PDOX model-selection and study plan
  • Growth, histology and project endpoint data
  • In vitro–in vivo comparison and report

Related models

Select the model by biological context

Study design

PDOX projects evaluate model selection and engraftment performance, with study duration and endpoints defined by the in vitro–in vivo plan.

PROJECT DISCUSSION

Extend PDO findings into a PDOX study

Share the PDO findings, candidate model, treatment and in vivo endpoints you want to confirm. Together we can define model selection, study groups, assays and scope.